SKI Market

A+| A| A-|

Indian Indices

Sensex

76,478.67 -249.70
( -0.33%)

Global Indices

Nasdaq

52,219.26 322.15
(0.62%)

Dow Jones

7,463.83 88.81
(1.20%)

Hang Seng

70,280.54 812.43
(1.17%)

Nikkei 225

10,511.26 27.04
(0.26%)

Forex

USD-INR

94.12 -0.28
(-0.30%)

EUR-INR

107.15 -0.14
(-0.13%)

GBP-INR

124.16 -0.32
(-0.26%)

JPY-INR

0.58 0.00
(-0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Titan Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524717

INE150C01029

41.3479918

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

59.92

1644.06

EPS(TTM)

Face Value()

Div & Yield %

6.64

0.13

Back

Consolidated Construction Consortium reports consolidated net profit of Rs 3.52 crore in the December 2025 quarter

Jan 31,2026

Net profit of Consolidated Construction Consortium reported to Rs 3.52 crore in the quarter ended December 2025 as against net loss of Rs 11.79 crore during the previous quarter ended December 2024. Sales rose 42.11% to Rs 74.14 crore in the quarter ended December 2025 as against Rs 52.17 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	74.14	52.17	42
OPM %	1.25	-54.61	-
PBDT	4.42	6.77	-35
PBT	3.86	5.53	-30
NP	3.52	-11.79	LP

76,478.67 -249.70 ( -0.33%)

52,219.26 322.15 (0.62%)

7,463.83 88.81 (1.20%)

70,280.54 812.43 (1.17%)

10,511.26 27.04 (0.26%)

94.12 -0.28 (-0.30%)

107.15 -0.14 (-0.13%)

124.16 -0.32 (-0.26%)

0.58 0.00 (-0.29%)